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Pulmonary hypertensionHeart failure is the ﬁnal common pathway of various cardiac pathologies and is associated with sudden cardiac
death, mostly caused by ventricular arrhythmias. In this paper we brieﬂy review the electrophysiological re-
modeling and the alterations in intracellular calcium handling, and the resulting arrhythmogenic mechanisms
associated with heart failure. Intercellular uncoupling and ﬁbrosis are identiﬁed as a major arrhythmogenic
factors. Diet and ventricular wall stretch are discussed as modulating factors. Finally, emphasis is placed on
the hitherto poorly studied aspects of right ventricular failure. This article is part of a Special Issue entitled:
Heart failure pathogenesis and emerging diagnostic and therapeutic interventions.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Heart failure is associated with life threatening ventricular ar-
rhythmias. Although about 50% of deaths in patients with heart
failure is caused by pump failure, the remainder is associated with
cardiac arrhythmias [1]. The mechanisms of these arrhythmias differ
and depend on the underlying electrophysiological changes caused
not only by heart failure itself but also by the processes that have
led to heart failure in the ﬁrst place.
The deﬁnition of heart failure is subject to debate, but it is gener-
ally considered a syndrome in which the pumping action of the heart
falls short to provide a sufﬁcient amount of blood and oxygen to the
organs (including the heart itself) [2,3]. Heart failure is the ﬁnal com-
mon pathway of a multitude of cardiac pathologies [2], the most
common of which is myocardial infarction. In the course of time
after the onset of myocardial infarction, the loss of myocardium and
the associated loss of contractile function are compensated by cardiacndation (grantNHS2007B018).
eart failure pathogenesis and
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el).
l rights reserved.hypertrophy. Eventually, this may result in failure. Other cardiovascular
diseases also eventually result in heart failure: (corrected) congenital
cardiac abnormalities, valve disease, hypertension, dilated cardiomyop-
athy, hypertrophic cardiomyopathy, Chagas' disease, arrhythmogenic
right ventricular cardiomyopathy, tachycardia dependent cardiomyop-
athy and so forth. The primary electrophysiological changes and the
mechanismof arrhythmogenesis associatedwith heart failure therefore
depend on the cause of heart failure. This is equally true for themecha-
nism of the trigger of the arrhythmia as for the electrophysiological
substrate. This is one of the explanations why cardiac arrhythmias
in heart failure are so difﬁcult to treat and why the choice of the thera-
peutic approach is not straightforward [4,5].
The electrophysiological changes during heart failure are, therefore,
multiple, and dependent on the underlying disease. They involve ion
channel remodeling, alterations in calcium handling, remodeling of
the extracellular matrix, the presence of scars, activation of the sympa-
thetic nervous system and the renin–angiotensin–aldosterone-system,
and dilatation and stretch. In addition, insufﬁcient blood supply associ-
ated with heart failure may also affect the heart and may lead to acute
myocardial ischemia, with its own arrhythmogenic mechanisms [6].
Thus, heart failure is not characterized by a single set of electrophysio-
logical changes.
As a consequence of the complexity of the electrophysiological
changes that may occur during heart failure, the scientiﬁc literature
on the subject is not unequivocal and highly dependent on the model
used to study these changes. Electrophysiological changes occurring in
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[7,8] do not necessarily mirror those observed in a dog model of infarc-
tion and pacing-induced heart failure [9], or those in a mouse model
with a junctophilin mutation [10]. In addition, patients with heart
failure receive pharmacological or non-pharmacological therapy to
increase hemodynamic function, to treat dyspnea, to synchronize con-
traction, or to suppress arrhythmias. These therapies are almost never
applied in animal models and this further limits translation of the
experimental data to the clinical situation.
This review focuses on some of the common denominators of heart
failure induced changes that are relevant for arrhythmogenesis, and
which include ion channel remodeling, cellular uncoupling, altered
calcium homeostasis, and extracellular matrix changes. A short sec-
tion will deal with the inﬂuence of myocardial stretch on electrophys-
iology. Because heart failure can be considered as a deﬁcit of energy
delivery, its development and electrophysiological consequences
heavily depend on the use of metabolic substrates. Some words will
therefore be dedicated to dietary modulation of heart failure in relation
to electrophysiological changes. Finally, a section will be dedicated to
the idiosyncrasies of right ventricular failure, an increasingly common
consequence of corrected congenital cardiac disease [11].
2. Ion channel remodeling
Action potential prolongation is a common feature in almost all
experimental models of heart failure [12,13] as well as in patients
with heart failure [8,14], and is an expression of reduced repolariza-
tion reserve [15]. Repolarization reserve is deﬁned as the ability to ef-
fect repolarization even if one of the repolarizing currents is reduced
(by drug action, genetic mutation, or disease) or if more depolarizing
current is present than normal. Indeed, T-wave changes as well as
QTc prolongation are seen clinically. The T-wave changes are often
explained as a consequence of myocardial strain. Direct evidence for
this is lacking, although tissue strain does affect ventricular repolari-
zation characteristics [16].
Another expression of reduced repolarization reserve is T-wave
alternans. It has been suggested that T-wave alternans is a predictor
of sudden cardiac death [17]. Indeed, during acute myocardial ische-
mia the onset of ventricular ﬁbrillation is preceded by overt T-wave
alternans [18]. Recently, techniques have been developed to quantify
subtle T-wave changes on a beat to beat basis clinically. Micro-T-wave
alternans analysis (MTWA) has been tested in a large group of pa-
tients with heart failure by Jackson et al. to study the applicability of
MTWA [19]. The authors concluded that in most cases the test was in-
determinate, if the test could be applied, and that the role of MTWA
for risk stratiﬁcation is meager.
The prolongation of the ventricular action potential in heart
failure (for review see [20,21]) is depicted schematically in Fig. 1
(reproduced from Michael et al. [20]) in association with the changes
in Ca2+-handling. It has been proposed that the AP-prolonging ef-
fects compensate for the loss of contraction by increasing the ampli-
tude and/or the duration of the Ca2+-transient. AP-prolongation
results from a reduction of the repolarizing currents Ito and IKs,
alone or in combination with an increase in a late inward current
carried by Na+. The latter current is almost non-existent in normal
myocardium. Terminal repolarization is postponed by a reduction of
IK1 in some models of severe heart failure. The latter also results
in a decreased stability of the resting membrane, by which the myo-
cardium becomes more susceptible to spontaneous depolarizations
(see following section).
The presence of sodium channel remodeling likely depends on the
model of heart failure used, although an increase in late sodium cur-
rent is a consistent ﬁnding. In a model of myocardial infarction in
dogs border zone myocytes demonstrate sodium channel remodeling
leading to a reduced peak sodium current [22]. This may contribute to
slowing of propagation.2.1. QT-prolongations and arrhythmogensis
A prolonged QT-interval in itself predisposes for the genesis of
early after depolarizations (EADs), which in turn may induce Torsade
des Pointes ventricular tachycardias or ventricular ﬁbrillation. In the
latter case the EADs act as a trigger for the arrhythmia with a reen-
trant mechanism. In a mapping study of a rabbit model of pressure
and volume overload a combined focal and reentrant mechanism of
arrhythmias has been described [23], compatible with this concept.
Myocardium excised from human hearts with heart failure also has
demonstrated EADs but not sustained arrhythmias. The mass of tissue
was apparently too small to support a reentrant arrhythmia [8].
Increased QT-dispersion in patients with heart failure [24] has
been associated with increased dispersion in repolarization, which
favors the initiation of a reentrant arrhythmia [25–27] especially if
combined with a critical degree of conduction slowing in the area
with the prolonged repolarization [28]. Cellular uncoupling may un-
mask intrinsic differences in repolarization [29] and thereby increase
repolarization heterogeneity. At the same time it may contribute to
conduction slowing and facilitate reentrant arrhythmias.
3. Intercellular uncoupling
3.1. Connexin43 expression and conduction
A decreased expression of the major gap junctional protein
connexin43 (Cx43) is also a general feature of heart failure. Cx43
expression is reduced by up to 50% and part of the protein is
dephosphorylated [29,30]. This protein is responsible for cell–cell
communication both electrically and physically (it permits the ex-
change of small molecules between cells). Whereas in the healthy
myocyte connexins are located preferentially at short sides of the
myocyte, the connexins redistribute during heart failure and are also
found along the long sides of the cell [31].
Cellular coupling is important for conduction of the cardiac im-
pulse, and a high degree of redundancy exists in the amount of
protein. Conduction changes occur only at large reductions of Cx43
[32–34] that are probably not reached during heart failure. However,
the combination of moderate intercellular uncoupling and a reduction
of sodium current could lead to conduction slowing [35]. However, in
a rabbit model of moderate to severe heart failure that is associated
with sudden cardiac death and arrhythmias a reduction of Cx43
expression was associated with a paradoxically increased epicardial
conduction velocity [36]. In that same model, QRS duration was
increased, because the increased conduction velocity could not fully
compensate for the increase in myocellular dimensions resulting
from hypertrophy [36].
Pharmacological tools have been developed to maintain the phos-
phorylation status of Cx43 and thereby increasing cellular coupling.
Indeed, rotigaptide administration leads to increased (atrial) conduc-
tion velocity and prevented ischemia induced conduction slowing
[37]. However, rotigaptide may also cause increased anisotropy of
conduction, and may eventually lead to transverse activation block
and arrhythmias [38].
Because Cx43 is part of a macromolecular complex in which the
sodium channel is also involved [32,39], it is to be expected that alter-
ations in one part of this macromolecular complex has consequences
for other parts. Therefore, sodium channel dysfunction likely accom-
panies Cx43 downregulation during heart failure, even in the absence
of a direct HF-induced effect on the sodium channel.
3.2. Connexin43 expression and repolarization
There is indirect evidence that intercellular uncoupling may also
impact on QT-changes in heart failure. In the same animal model of
heart failure as described above [36] QT prolongation was observed
Fig. 1. A schematic diagram showing the changes in Ca2+-handling and contractility and the potential compensatory function of ion-channel remodeling that causes action poten-
tial (AP) duration (APD) prolongation in congestive heart failure. A. A normal cardiac AP, along with associated changes in free intracellular Ca2+-activity (upward deﬂection in-
dicates increased Ca2+-concentration) and systolic cell contraction (downward deﬂection indicates cell length decrease). B. Ca2+-concentrations and cell contraction in the failing
heart are shown by the green dotted lines. Decreased systolic Ca2+- release impairs cellular contractility and causes APD-prolonging ion current remodeling (changes are indicated
by the arrows indicating increases or decreases in speciﬁc currents).
Reproduced with permission from ref [20]
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prolongation was not observed in isolated ventricular myocytes
obtained from the same hearts at a (physiological) stimulation rate
of 4 Hz (Fig. 2), although it was observed at physiologically irrelevant
low heart rates,. In transmural tissue samples taken from the LV
free wall of HF rabbit hearts, connexin43 expression was reduced by
≈50% [36]. Yet, the transmural conduction velocity was unchanged
and amounted to 24–25 cm/s, [36,29] suggesting that the negative
effect of intercellular uncoupling on transmural conduction velocity
is compensated by the increase in cell dimensions, which facilitates
conduction [36]. The net effect of the unchanged conduction velocity
and the increased cell dimensions was an increased transmural
activation time. This was corroborated in computer simulations of a
transmural strand of 200 myocytes (ﬁrst 100 with endocardial char-
acteristics (long action potential, Ito absent), next 100 with epicardal
characteristics (short action potential, Ito large) [41]), as diagrammed
in Fig. 2D (left). Under control conditions, the model, fed with the
mean control cell dimensions of Fig. 2B, required a gap junctional
conductance (gj) of 8 μS to assure a conduction velocity of 25 cm/s.
The subepicardial cells repolarized to 90% ≈2 ms before the
subendocardial cells (Fig. 2D, middle). If gj was halved to 4 μS and
the mean HF cell dimensions (Fig. 2B) were used while the intrinsic
action potential characteristics were maintained, the conduction ve-
locity remained 24–25 cm/s, but the transmural activation time was
increased by ≈10 ms. As a result, the time from ﬁrst activation to
last repolarization (90%) had increased about 7 ms in the HF simula-
tion compared to the control condition. In addition, the subepicardial
cells repolarized later than the subendocardial cells (Fig. 2D, right).
These simulations show that the decreased coupling observed
during HF causes 1) an increase in transmural activation times and
2) unmasking of the intrinsic heterogeneity in repolarization. The
combination of these effects results in a prolongation of the time be-
tween earliest activation and last repolarization andmay explain both
the increase in QT-interval in the paradoxical presence of unchanged
action potential duration, and the inversion of the T-wave as ob-
served experimentally. Although the effects from this simulation ofa strand of myocardium appear small, they may be more pronounced
in an entire heart.
4. Altered calcium homeostasis
Heart failure is associated with altered calcium handling. Where-
as a healthy heart demonstrates a positive force–frequency relation,
it is reversed in failing hearts. This is reﬂected in the reversed fre-
quency dependence of the amplitude of the Ca2+-transients in
heart failure [42]. In addition, the diastolic Ca2+-concentration is
elevated [42]. The sarcoplasmic (SR) calcium content is decreased
in a stimulation rate-dependent manner, leading to a smaller ampli-
tude of the Ca2+-transient especially at higher heart rates. Also,
the SR Ca2+-ATPase is down regulated, leading to a slower reuptake
of Ca2+ into the SR and a slowing of relaxation [43]. These condi-
tions allow the occurrence of spontaneous Ca2+-releases from the
SR (‘Ca2+-sparks’) [44].
During heart failure the sarcolemmal Na+/Ca2+ exchanger (NCX)
is upregulated and allows the removal of Ca2+ out of the cell [43]. Be-
cause the NCX is electrogenic and moves three sodium ions against
one calcium ion, it may generate an inward current under conditions
of intracellular calcium overload. Spontaneous calcium release events,
therefore, are accompanied by transient depolarizations of the resting
membrane, showing as delayed after depolarizations (DADs). These
DADs may in turn trigger full action potentials and cause arrhythmias
based on triggered activity (see Fig. 3) [21,42]. Prolongation of the
action potential (see above) may contribute to this arrhythmogenic
mechanisms when it is accompanied by a shortening of the diastolic
interval which reduces the time available to remove excess cytoplas-
mic Ca2+.
Altered intracellular calcium homeostasis in heart failure does not
only have consequences for the transmembrane current, SR-loading
and arrhythmogenesis, but also for various signaling pathways in
which Ca2+ is centrally involved, amongst others in hypertrophic sig-
naling and cell death [45]. This topic impacts on the structural changes
occurring in heart failure that may inﬂuence arrhythmogenesis but is
Fig. 2. QT prolongation and intercellular uncoupling. A. Typical ECG traces (lead I) from a control rabbit (Ctrl) and from a rabbit with heart failure (HF) and QTc intervals (n: number
of animals, data from Den Ruijter et al. [40]). Bars show mean ± SEM. Asterisks indicate signiﬁcant difference (p b 0.05, HF vs. control). Note the inversion of the T-wave in HF.
B. Photographs of an isolated ventricular myocyte from a control rabbit (top) and from a rabbit with HF (bottom), cell length and (n: number of hearts, 50 myocytes/heart, data
from Verkerk et al. [101]), and cell capacitance of 38 control and 20 HF myocytes (data from Verkerk et al. [101]). C. Action potentials recorded from ventricular myocytes isolated
from a control rabbit (top) and from a rabbit with HF (bottom) and associated action potential duration at 90% repolarization (APD90) (n: number of myocytes). Action potentials
elicited at 4 Hz and recorded with the perforated patch clamp technique. Data from Den Ruijter et al. [40]. Bars show mean ± SEM. Asterisks indicate signiﬁcant difference
(p b 0.05, HF vs. control). D. Effect of intercellular uncoupling as observed in HF on endocardial and epicardial action potentials as observed in the 10th cell from the endocardial
side (solid line labelled ‘endo’) and in the 10th cell from the epicardial side (dashed line labelled ‘epi’) in a simulated strand of 200 transversally arranged myocytes coupled by a gap
junctional conductance gj. Action potentials elicited at 4 Hz by a stimulus applied to the ﬁrst cell at the endocardial side. The horizontal line in panel D represents the time from
earliest activation to last repolarization under control conditions.
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5. Extracellular matrix
During heart failure themyocardium undergoes structural changes
that lead to ﬁbrosis [46,47]. Fig. 4A shows picrosirius red staining of
left ventricular apical biopsies obtained during cardiac transplantation
(lower two panels) in comparison with a control biopsy from rejected
donor hearts (considered as a normal control biopsy) [48]. Panel B
shows the quantiﬁcation of ﬁbrosis indicating an increased amount
of ﬁbrosis in the hearts from patients with end-stage heart failure
(n = 15) compared to control (n = 10). It cannot be excluded
that a difference in age may have contributed to the difference in ﬁ-
brosis, but the ﬁgure suggests that HF is associated with the ﬁbrosis.
The data could be reproduced in a mouse model of heart failure
(after transaortic constriction) in which the ages of the mice were
similar [48].
The altered extracellular matrix contributes to a decrease in dia-
stolic function of the heart. For cardiac electrophysiology it is impor-
tant that the collagenous septa separating the myocardial ﬁbers may
impede propagation of the cardiac impulse, especially transverse to
ﬁber direction, by disruption of the (lateral) intercellular coupling.The resulting increased anisotropy may not only facilitate the genesis
of a focal arrhythmia [49], but may also contribute to current-to-load
mismatch conditions and conduction block, especially when the
sodium and calcium currents are reduced [50]. The arrhythmogenic
potential of subtle structural alteration in combination with sodium
channel dysfunction is demonstrated in patients with Brugada syn-
drome who are at increased risk for sudden cardiac death and many
of whom have structural changes in the right ventricular outﬂow
tract in combination with a sodium channel mutation [51].
Fibrosis is associated with electrogram fractionation. Spach et al.
have shown how electrogram morphology depends on anisotropy
[52]. In the setting of myocardial infarction De Bakker et al. have
shown how the various components of a fractionated local electro-
gram correspond to propagation in an individual muscle ﬁber of a
human left ventricular papillary muscle obtained during cardiac
transplantation [53]. Activation in the ﬁbrotic muscle propagated
in a zig-zag fashion along the electrically isolated ﬁbers, and led to a
signiﬁcant activation delay, although conduction velocity in the indi-
vidual ﬁbers was not slowed [53]. In these cases the activation delay
was caused by the large increment in the length of the activation
path, and not by a depression of sodium channel function. Activation
delay over a small distance facilitates reentrant activation, particularly
in combination with a shortened refractory period [25].
Fig. 3. Fish oil prevents triggered activity. A. Representative examples of the tracing
periods. Arrows indicate last paced AP. Note that the pacing period is followed by a
delayed after depolarization (DAD) and triggered activity in hearts from animals with
heart failure (HF) (HF-control) but not in healthy hearts (Control). B. Data summary
of the number of triggered APs and delayed after depolarizations (DADs). Bars show
mean ± SEM. *p b 0.05 vs HF-control and ‡p b 0.05 vs. HF-ω9 (one-way ANOVA).
Reproduced with permission from ref [40].
Fig. 4. Increased ﬁbrosis in hearts from patients with end-stage heart failure, with and
without ventricular arrhythmias (VT+, VT−; n = 7 and n = 8, respectively), who
underwent cardiac transplantation. Ctrl denotes hearts from heart donors (n = 7).
CHF: congestive heart failure. Bars show mean ± SEM. * statistically signiﬁcant differ-
ence vs. Ctrl.
Reproduced with permission from [48].
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Fine structural changes similar to those that occur in heart failure
may thus contribute signiﬁcantly to arrhythmogenesis. The depen-
dence of fractionation during premature stimulation was applied clin-
ically to identify patients at risk of sudden death [54]. Kawara et al.
have described the conditions for the occurrence of fractionated uni-
polar electrograms in explanted hearts from patients with end-stage
heart failure [55]. It appeared that activation delay increased with
progressively shorter coupling intervals, especially when the direc-
tion of propagation was perpendicular to ﬁber direction, and when
ﬁbrosis was organized into long ﬁbrotic strands. Diffuse ﬁbrosis was
not associated with the activation delay [55].
6. Arrhythmogenic mechanisms
The mechanism of arrhythmogenesis depends on the myocardial
structure in combination with the degree of electrophysiological
remodeling and Ca2+-handling alterations. Whereas the latter two
deﬁne the mechanism of initiation (‘the trigger’) of the arrhythmia,
the structure deﬁnes the mechanisms of the continuation of the
arrhythmia in combination with spatial heterogeneities in the degree
of electrophysiological remodeling. These considerations have conse-
quences for the choice of therapy.
Fig. 5 summarizes the complex manner in which structural and
functional changes that occur during heart failure interact to lead to
arrhythmias. Cellular ionic remodeling and altered Ca2+-handling
(left upper panel) cause the generation of EADs and DADs, that may
lead to a triggered premature beat. If this premature beat is coincidentwith a suitable substrate (repolarization heterogeneity, uncoupling
and/or ﬁbrosis, left lower panel) reentry may ensue. Dependent on
the extent of the scar or the degree of organization of ﬁbrosis a large
or small reentrant circuit may be set up (right lower panel). In the
case of a large reentrant circuit (with the circuit length being larger
than the wavelength, deﬁned as the mathematical product of local
conduction velocity and local refractory period) an excitable gap, a pe-
riod between repolarization and the subsequent activation, will exist
during which the cell membrane has regained its resting membrane
potential. With a ﬁner structure of ﬁbrosis (or uncoupling) reentry
of a different nature will be more likely to develop, with a smaller or
even absent excitable gap. Although the relation between the type of
reentry and tissue architecture has not been accurately described,
it is likely that in hearts with diffuse ﬁbrosis one or more rotors may
maintain the arrhythmiawhereby the tissue discontinuitiesmay func-
tion as (temporary) anchoring points for the mother rotor [56]. If
triggered activity persists (right upper panel) it may in itself be the
mechanism for focal perpetuation of the arrhythmia, unless it converts
into reentry.
Therapeutic options depend on this conglomerate of factors. For
example, catheter ablation therapy may allow modulation of the sub-
strate if a single focus exists, or if a reentrant activation circuit follows
a ﬁxed pathway. An organized myocardial scar evidently may form
the basis of a macro-reentrant circuit, whereas ﬁne structural abnor-
malities tend to be associated with a wandering rotor that has multi-
ple anchoring points at the abundant tissue heterogeneities [57].
AP prolongation
•EADs
Altered Ca-handling
- DADs
Triggered arrhythmias (focal)Triggers (cellular)
AP prolongation
•Heterogeneity in repolarization
Substrate (multicellular)
Large scar
Organized fibrosis
Fine fibrosis
macroreentry + excitable gap
wandering rotor
anchoring points
reentry, no excitable gap
Reentrant arrhythmias
DAD
EAD
Uncoupling and fibrosis
•Heterogeneity in conduction
Fig. 5. Diagram of the interaction between the cellular and multicellular arrhythmogenic mechanisms leading to arrhythmogenesis in heart failure.
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the substrate is based on a wandering rotor in a substrate of ﬁne
ﬁbrosis. The challenge for clinical cardiology is to identify the type
of structural remodeling in each patient with heart failure and there-
by to identify the best therapeutic options.
Apart from the key requirements for arrhythmogenesis, many
modulatory factors play a role [58]. Examples of the modulation of
the triggering and substrate are the inﬂuence of the autonomic ner-
vous system, pharmacological treatment, mechanical action of the
heart and diet. We will brieﬂy discuss the latter two of these factors.
Some of the other modulating factors are discussed elsewhere in this
issue (references to be provided by editor).
7. Modulation
7.1. Wall motion
Heart failure is a common consequence of myocardial infarction
and often involves abnormal wall motion in some parts of the heart.
Abnormal wall motion is a strong predictor of sudden cardiac death
[59]. Myocardial stretch and dilatation are associated with opening
of stretch sensitive ion channels and with arrhythmias [16,60,61].
Kamkin et al. have demonstrated that myocytes from human, guinea
pig and rat hearts showmembrane depolarization upon stretching, ac-
tion potential prolongation and spontaneous activity. The membrane
current underlying these changes was inhibited by Gadolinium, and
the changes were more outspoken in hypertrophied myocytes [62].
In a recent paper, Opthof et al. have reported on the role of wall
motion abnormalities on dispersion in repolarization in patients
(with and without previous myocardial infarction) undergoing car-
diac surgery [63]. Local unipolar electrograms were obtained from
up to 72 left ventricular epicardial sites and activation recovery
intervals (ARIs) were measured as an index of action potential dura-
tion. Wall motion was measured simultaneously with esophagealechocardiography in 9 left ventricular regions of the heart. It appeared
that in the presence of wall motion abnormalities the difference of
ARIs between the 9 regions of the heart was larger than in patients
without wall motion abnormalities, independent of the presence of
myocardial infarction. Importantly, the overall increased dispersion
in ARIs was caused by increased dispersion of ARIs within the normal-
ly moving myocardium. The dispersion in ARIs also was associated
with dispersion in repolarization time, which forms one of the re-
quired substrates for the initiation of reentry [25,27]. In summary,
these data suggest that wall motion abnormalities may directly create
or increase the substrate for reentrant arrhythmias [63].
7.2. Diet
The GISSI study has demonstrated that a diet rich in ﬁsh oil
(resembling the Mediterranean diet) reduces the risk of sudden car-
diac death in a large population of patients with a prior myocardial
infarction [64]. There is ample experimental evidence for the effects
of ﬁsh oil fatty acids on myocardial electrophysiology [65]. Acute ad-
ministration of ﬁsh oil prevented ventricular ﬁbrillation in dogs [66].
Dietary supplementation with ﬁsh oil fatty acids causes a reduction of
the action potential duration in pigs [67] andmay thus antagonize the
heart failure induced prolongation of the action potential duration
and its arrhythmogenic consequences (see also Fig. 3) [68]. In addi-
tion to these direct electrophysiological effects of ﬁsh oil fatty acids,
a diet rich in unsaturated fatty acids may force energy metabolism
of the cardiac myocyte towards maintenance of beta-oxidation and
slow development of heart failure [40]. The latter mechanism estab-
lishes an indirect effect that results in less arrhythmogenesis.
Action potential shortening is anti-arrhythmic if the primary
arrhythmogenic mechanism is based on action potential prolonga-
tion, but it may be pro-arrhythmic when the primary mechanism
is based on reentry, because in the latter case it may reduce wave
length [65]. Indeed, pro-arrhythmic effects of dietary ﬁsh oil fatty
2438 R. Coronel et al. / Biochimica et Biophysica Acta 1832 (2013) 2432–2441acids have been described [69,70]. This paradox may explain why
studies involving a net effect of dietary ﬁsh oil supplementation in
large patient groups has not been demonstrated [71].
8. Right ventricular failure
Right ventricular (RV) failure develops as a consequence of a
variety of pathological condition such as RV infarction, pulmonary
hypertension, genetic disorders (e.g. arrhythmogenic right ventricu-
lar cardiomyopathy (ARVC)), or in the context of corrected congenital
cardiac disease such as surgical repair of Tetralogy of Fallot (TOF). It
can also occur secondary to left-sided heart failure. Lou et al. describe
pro-arrhythmic electrophysiological remodeling in ex vivo human
RVs regardless of the anatomical origin (left or right side) of heart
failure [72] suggesting that the RV might be involved in arrhythmia
generation and maintenance independent of the ventricular origin
of heart failure.
Although RV arrhythmias and sudden cardiac death are common
features of these pathological conditions [73], the electrophysiological
remodeling and the mechanisms involved in arrhythmia generation
in the failing RV remain relatively understudied compared to the left
ventricle (LV).
APD prolongation, a hallmark of LV heart failure, has also been con-
sistently observed in the failing RV myocardium [74–76]. On the ECG
of patientswith RV dysfunction, this prolongation is typically reﬂected
by an increased duration of the QT-interval [77–79] although a con-
comitant electrophysiological remodeling of the LV is also likely to
contribute to this effect [80]. In the pressure-overloaded RV of the
rat, the APD prolongation appeared to be related to a decrease in the
expression of the main potassium channels [76]. APD dispersion is
also increased in the failing RV when measured in isolated ventricular
myocytes [81] and at the RV epicardial surface of perfused isolated
hearts where the right ventricular outﬂow tract shows the longest
APD [82].
Conduction abnormalities are commonly found in right heart
failure and are linked not only to changes in the expression, localiza-
tion and phosphorylation of gap junctions [83,84], altered sodium cur-
rent properties [85], and ﬁbrosis [86] but also to scars in ARVC and TOF0 10 20 30 40 50 60 70 80 90 1000.16
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Fig. 6. T-wave alternans of the in vivo ECG in the failing RV of pulmonary hypertensive rat
transient alternans in isolated RV myocytes. A. ECG trace (top) from a rat with RV failure an
alternans over 93 consecutive beats. T-wave alternans was observed in a proportion of failin
difference over two consecutive beats showing discordant APD alternans between region a
showed RV discordant APD alternans when electrically stimulated above 10 Hz. C. Traces
myocyte paced at 9 Hz. A majority of isolated failing RV myocytes displayed alternans w
permission from cu.patients after corrective surgery [87,88]. Indeed, an increased duration
of the QRS interval of patients with repaired TOF or ARVC reﬂects acti-
vation delays [89,90] and loss of synchronicity [91,92]. The presence
of QRS fragmentation, which is related to scar size, is a good predictor
of arrhythmias in these pathological conditions [93,94]). Electrical
maladaptation to a change rate observed in the failing RV in the
form of steep APD and conduction velocity (CV) restitution curves,
could lead to alternans, an established predictor of sudden cardiac
death [17,82,95].
As in LV failure, altered calcium homeostasis is also likely to play an
important role in RV dysfunction and arrhythmogenesis. Sarcoplasmic
reticulum (SR) calcium leak has been described in ARVC where it has
been shown to be related to mutations of the ryanodine receptor
[96]. SR calcium leak was also described in failing RV myocytes of
pulmonary hypertensive rats but the underlying mechanisms were
different and involved a SR calcium overload likely to be related to
(i) an increased calcium entry due to the APD prolongation and (ii) a
decreased sodium/calcium exchanger function [82]. In the latter
study calcium transient alternans was commonly observed at high
pacing rates (9 Hz). This may contribute to or result from electrical
alternans observed in vivo and ex vivo in these failing animals (Fig. 6).
The speciﬁc shape and thickness of the RV make it sensitive to
changes in diastolic volume and the failing RV is typically dilated and
thus exposed to a greater level of stretch than its left counterpart.
RV stretch consecutive to chronic pulmonary regurgitation has been
shown to contribute to arrhythmia generation by decreasing APD
(unlike the APD increase commonly observed in models of pulmonary
hypertension), increasing APD dispersion and slowing conduction ve-
locity [97] via the activation of mechanosensitive channels (see [98]
for review). In patients with repaired TOF, a good correlation has been
foundbetweenRVdilatation, QRS duration and the incidence of ventric-
ular tachycardia [99] and RV mechanical dispersion was increased in
ARVC patients presenting with life-threatening arrhythmias [100].
9. Conclusion
The cellular and extracellular remodeling occurring during heart
failure set the stage, alone or in combination, stage for life-threatening0 100 200 300 400 500
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g rats in which they represented more than 9% of the analyzed beats. B. Map of APD80
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showing simultaneous cell shortening and calcium transient alternans in a failing RV
hen paced at 9 Hz, control cells did not (P b 0.001). Reproduced and modiﬁed with
2439R. Coronel et al. / Biochimica et Biophysica Acta 1832 (2013) 2432–2441arrhythmias. Reentrant as well as triggered arrhythmias of different
types may ensue, each of which requires a different therapeutic ap-
proach. The identiﬁcation of the primary arrhythmia mechanism in
each individual heart failure patient and of the matched therapeutic
approach poses a challenge to clinical cardiology.References
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